{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T17:31:20Z","timestamp":1762018280911,"version":"3.37.3"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2 TR002534","K23AR075099","R01 DK122554-01"],"award-info":[{"award-number":["KL2 TR002534","K23AR075099","R01 DK122554-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010874","name":"American Society for Bone and Mineral Research","doi-asserted-by":"publisher","award":["Rising Star Award"],"award-info":[{"award-number":["Rising Star Award"]}],"id":[{"id":"10.13039\/100010874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s11914-020-00598-z","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T09:03:12Z","timestamp":1591347792000},"page":"371-377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Update on the Acute Effects of Glucose, Insulin, and Incretins on Bone Turnover In Vivo"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6388-8201","authenticated-orcid":false,"given":"Vanessa D.","family":"Sherk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Schauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viral N.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"issue":"2","key":"598_CR1","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00198-011-1600-7","volume":"23","author":"M Iki","year":"2012","unstructured":"Iki M, Tamaki J, Fujita Y, Kouda K, Yura A, Kadowaki E, et al. Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) study. Osteoporos Int. 2012;23(2):761\u201370.","journal-title":"Osteoporos Int"},{"key":"598_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2147\/TCRM.S131945","volume":"13","author":"A Moayeri","year":"2017","unstructured":"Moayeri A, Mohamadpour M, Mousavi S, Shirzadpour E, Mohamadpour S, Amraei M. Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis. Ther Clin Risk Manag. 2017;13:455\u201368.","journal-title":"Ther Clin Risk Manag"},{"issue":"4","key":"598_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/MED.0000000000000421","volume":"25","author":"VN Shah","year":"2018","unstructured":"Shah VN, Carpenter RD, Ferguson VL, Schwartz AV. Bone health in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2018;25(4):231\u20136.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"598_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.bone.2019.01.005","volume":"121","author":"M Iki","year":"2019","unstructured":"Iki M, Fujita Y, Kouda K, Yura A, Tachiki T, Tamaki J, et al. Hyperglycemic status is associated with an elevated risk of osteoporotic fracture in community-dwelling elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) cohort study. Bone. 2019;121:100\u20136.","journal-title":"Bone"},{"issue":"3","key":"598_CR5","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1530\/EJE-16-0652","volume":"176","author":"K Hygum","year":"2017","unstructured":"Hygum K, Starup-Linde J, Harsl\u00f8f T, Vestergaard P, Langdahl BL. MECHANISMS IN ENDOCRINOLOGY: diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. Eur J Endocrinol. 2017;176(3):R137\u201357.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"598_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nrendo.2016.153","volume":"13","author":"N Napoli","year":"2017","unstructured":"Napoli N, et al. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. 2017;13(4):208\u201319.","journal-title":"Nat Rev Endocrinol"},{"key":"598_CR7","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.bone.2019.03.039","volume":"123","author":"VN Shah","year":"2019","unstructured":"\u2022 Shah VN, et al. Type 1 diabetes onset at young age is associated with compromised bone quality. Bone. 2019;123:260\u20134 Timing of T1D onset and bone.","journal-title":"Bone"},{"key":"598_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bone.2015.11.004","volume":"83","author":"J Starup-Linde","year":"2016","unstructured":"Starup-Linde J, Lykkeboe S, Gregersen S, Hauge EM, Langdahl BL, Handberg A, et al. Differences in biochemical bone markers by diabetes type and the impact of glucose. Bone. 2016;83:149\u201355.","journal-title":"Bone"},{"key":"598_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bone.2015.02.019","volume":"82","author":"J Starup-Linde","year":"2016","unstructured":"Starup-Linde J, Vestergaard P. Biochemical bone turnover markers in diabetes mellitus - a systematic review. Bone. 2016;82:69\u201378.","journal-title":"Bone"},{"issue":"4","key":"598_CR10","doi-asserted-by":"publisher","first-page":"e2991","DOI":"10.1002\/dmrr.2991","volume":"34","author":"N Napoli","year":"2018","unstructured":"Napoli N, Pannacciulli N, Vittinghoff E, Crittenden D, Yun J, Wang A, et al. Effect of denosumab on fasting glucose in women with diabetes or prediabetes from the FREEDOM trial. Diabetes Metab Res Rev. 2018;34(4):e2991.","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"598_CR11","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/jdi.12944","volume":"10","author":"M Karimi Fard","year":"2019","unstructured":"Karimi Fard M, Aminorroaya A, Kachuei A, Salamat MR, Hadi Alijanvand M, Aminorroaya Yamini S, et al. Alendronate improves fasting plasma glucose and insulin sensitivity, and decreases insulin resistance in prediabetic osteopenic postmenopausal women: a randomized triple-blind clinical trial. J Diabetes Investig. 2019;10(3):731\u20137.","journal-title":"J Diabetes Investig"},{"issue":"5","key":"598_CR12","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1210\/jc.2014-3481","volume":"100","author":"KA Toulis","year":"2015","unstructured":"Toulis KA, Nirantharakumar K, Ryan R, Marshall T, Hemming K. Bisphosphonates and glucose homeostasis: a population-based, retrospective cohort study. J Clin Endocrinol Metab. 2015;100(5):1933\u201340.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"598_CR13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.bone.2011.04.017","volume":"50","author":"M Ferron","year":"2012","unstructured":"Ferron M, McKee MD, Levine RL, Ducy P, Karsenty G. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone. 2012;50(2):568\u201375.","journal-title":"Bone"},{"issue":"1","key":"598_CR14","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1038\/s41598-020-58760-7","volume":"10","author":"B Riquelme-Gallego","year":"2020","unstructured":"Riquelme-Gallego B, Garc\u00eda-Molina L, Cano-Ib\u00e1\u00f1ez N, S\u00e1nchez-Delgado G, And\u00fajar-Vera F, Garc\u00eda-Fontana C, et al. Circulating undercarboxylated osteocalcin as estimator of cardiovascular and type 2 diabetes risk in metabolic syndrome patients. Sci Rep. 2020;10(1):1840.","journal-title":"Sci Rep"},{"issue":"52","key":"598_CR15","doi-asserted-by":"publisher","first-page":"E11238","DOI":"10.1073\/pnas.1707876115","volume":"114","author":"SP Kim","year":"2017","unstructured":"Kim SP, Frey JL, Li Z, Kushwaha P, Zoch ML, Tomlinson RE, et al. Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes. Proc Natl Acad Sci U S A. 2017;114(52):E11238\u201347.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"598_CR16","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1210\/jc.2018-00176","volume":"103","author":"H Maagensen","year":"2018","unstructured":"\u2022 Maagensen H, et al. Bone turnover markers in patients with nonalcoholic fatty liver disease and\/or type 2 diabetes during oral glucose and isoglycemic intravenous glucose. J Clin Endocrinol Metab. 2018;103(5):2042\u20139 Compared the BTM response to different routes of glucose administration between T2D and healthy controls.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"598_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1530\/EC-15-0022","volume":"4","author":"KK Ivaska","year":"2015","unstructured":"Ivaska KK, et al. The effects of acute hyperinsulinemia on bone metabolism. Endocr Connect. 2015;4(3):155\u201362.","journal-title":"Endocr Connect"},{"key":"598_CR18","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.12659\/MSM.896469","volume":"22","author":"SK Xiang","year":"2016","unstructured":"Xiang SK, Wan JB, Jiang XH, Zhu YH, Ma JH, Hua F. Effect of intravenous glucose tolerance test on bone turnover markers in adults with normal glucose tolerance. Med Sci Monit. 2016;22:2602\u20137.","journal-title":"Med Sci Monit"},{"issue":"2","key":"598_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s00223-011-9551-8","volume":"90","author":"PM Paldanius","year":"2012","unstructured":"Paldanius PM, et al. The effect of oral glucose tolerance test on serum osteocalcin and bone turnover markers in young adults. Calcif Tissue Int. 2012;90(2):90\u20135.","journal-title":"Calcif Tissue Int"},{"key":"598_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.bone.2017.01.027","volume":"97","author":"S Westberg-Rasmussen","year":"2017","unstructured":"\u2022 Westberg-Rasmussen S, et al. Differential impact of glucose administered intravenously or orally on bone turnover markers in healthy male subjects. Bone. 2017;97:261\u20136 Delineates the role of glucose recovery route on bone turnover.","journal-title":"Bone"},{"key":"598_CR21","doi-asserted-by":"publisher","first-page":"115230","DOI":"10.1016\/j.bone.2020.115230","volume":"133","author":"R Fuglsang-Nielsen","year":"2020","unstructured":"Fuglsang-Nielsen R, Rakvaag E, Vestergaard P, Hartmann B, Holst JJ, Hermansen K, et al. Consumption of nutrients and insulin resistance suppress markers of bone turnover in subjects with abdominal obesity. Bone. 2020;133:115230.","journal-title":"Bone"},{"key":"598_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13098-015-0006-7","volume":"7","author":"LS Lopes","year":"2015","unstructured":"Lopes LS, et al. The role of enteric hormone GLP-2 in the response of bone markers to a mixed meal in postmenopausal women with type 2 diabetes mellitus. Diabetol Metab Syndr. 2015;7:13.","journal-title":"Diabetol Metab Syndr"},{"issue":"4","key":"598_CR23","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1210\/jc.2016-3282","volume":"102","author":"KT Tonks","year":"2017","unstructured":"\u2022 Tonks KT, et al. Bone turnover is suppressed in insulin resistance, independent of adiposity. J Clin Endocrinol Metab. 2017;102(4):1112\u201321 Separates the effect of obesity from insulin resistance on the BTM response to a hyperinsulinemic-euglycemic clamp.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"598_CR24","first-page":"629","volume":"20","author":"GB Fuusager","year":"2019","unstructured":"Fuusager GB, Christesen HT, Milandt N, Schou AJ. Glycemic control and bone mineral density in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2019;20(5):629\u201336.","journal-title":"Pediatr Diabetes"},{"issue":"8","key":"598_CR25","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1210\/jc.2019-00084","volume":"104","author":"SC Chen","year":"2019","unstructured":"Chen SC, Shepherd S, McMillan M, McNeilly J, Foster J, Wong SC, et al. Skeletal fragility and its clinical determinants in children with type 1 diabetes. J Clin Endocrinol Metab. 2019;104(8):3585\u201394.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"598_CR26","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jocd.2018.06.007","volume":"22","author":"AL Carvalho","year":"2019","unstructured":"Carvalho AL, Massaro B, Silva LTP, Salmon CEG, Fukada SY, Nogueira-Barbosa MH, et al. Emerging aspects of the body composition, bone marrow adipose tissue and skeletal phenotypes in type 1 diabetes mellitus. J Clin Densitom. 2019;22(3):420\u20138.","journal-title":"J Clin Densitom"},{"issue":"6","key":"598_CR27","doi-asserted-by":"publisher","first-page":"9338","DOI":"10.1002\/jcp.27617","volume":"234","author":"FR Carvalho","year":"2019","unstructured":"Carvalho FR, Calado SM, Silva GA, Diogo GS, Moreira da Silva J, Reis RL, et al. Altered bone microarchitecture in a type 1 diabetes mouse model Ins2(Akita). J Cell Physiol. 2019;234(6):9338\u201350.","journal-title":"J Cell Physiol"},{"issue":"10","key":"598_CR28","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1210\/jc.2019-00035","volume":"104","author":"DR Weber","year":"2019","unstructured":"Weber DR, Gordon RJ, Kelley JC, Leonard MB, Willi SM, Hatch-Stein J, et al. Poor glycemic control is associated with impaired bone accrual in the year following a diagnosis of type 1 diabetes. J Clin Endocrinol Metab. 2019;104(10):4511\u201320.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"598_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1042\/bj0010028","volume":"1","author":"B Moore","year":"1906","unstructured":"Moore B. On the treatment of diabetes mellitus by acid extract of duodenal mucous membrane. Biochem J. 1906;1(1):28\u201338.","journal-title":"Biochem J"},{"key":"598_CR30","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3389\/fendo.2018.00387","volume":"9","author":"JF Rehfeld","year":"2018","unstructured":"Rehfeld JF. The origin and understanding of the incretin concept. Front Endocrinol (Lausanne). 2018;9:387.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Suppl 1","key":"598_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/dom.13129","volume":"20","author":"MA Nauck","year":"2018","unstructured":"Nauck MA, Meier JJ. Incretin hormones: their role in health and disease. Diabetes Obes Metab. 2018;20(Suppl 1):5\u201321.","journal-title":"Diabetes Obes Metab"},{"key":"598_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bone.2014.02.013","volume":"63","author":"G Mabilleau","year":"2014","unstructured":"Mabilleau G, Mieczkowska A, Irwin N, Simon Y, Audran M, Flatt PR, et al. Beneficial effects of a N-terminally modified GIP agonist on tissue-level bone material properties. Bone. 2014;63:61\u20138.","journal-title":"Bone"},{"issue":"11","key":"598_CR33","doi-asserted-by":"publisher","first-page":"E2325","DOI":"10.1210\/jc.2014-2547","volume":"99","author":"A Nissen","year":"2014","unstructured":"Nissen A, Christensen M, Knop FK, Vilsb\u00f8ll T, Holst JJ, Hartmann B. Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans. J Clin Endocrinol Metab. 2014;99(11):E2325\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"598_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bone.2019.05.014","volume":"125","author":"K Skov-Jeppesen","year":"2019","unstructured":"\u2022 Skov-Jeppesen K, et al. GLP-2 and GIP exert separate effects on bone turnover: a randomized, placebo-controlled, crossover study in healthy young men. Bone. 2019;125:178\u201385 Testing direct effect of gut hormones on bone.","journal-title":"Bone"},{"issue":"1","key":"598_CR35","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1210\/jc.2017-01949","volume":"103","author":"MB Christensen","year":"2018","unstructured":"\u2022\u2022 Christensen MB, et al. Glucose-dependent insulinotropic polypeptide (GIP) inhibits bone resorption independently of insulin and glycemia. J Clin Endocrinol Metab. 2018;103(1):288\u201394 Demonstrates GIP affects bone turnover independent of glucose and insulin in T1D.","journal-title":"J Clin Endocrinol Metab"},{"key":"598_CR36","doi-asserted-by":"publisher","first-page":"170178","DOI":"10.1016\/j.peptides.2019.170178","volume":"125","author":"MB Christensen","year":"2020","unstructured":"Christensen MB, Gasbjerg LS, Heimb\u00fcrger SM, Stensen S, Vilsb\u00f8ll T, Knop FK. GIP\u2019s involvement in the pathophysiology of type 2 diabetes. Peptides. 2020;125:170178.","journal-title":"Peptides"},{"key":"598_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1472-6793-11-12","volume":"11","author":"EL Pacheco-Pantoja","year":"2011","unstructured":"Pacheco-Pantoja EL, Ranganath LR, Gallagher JA, Wilson PJM, Fraser WD. Receptors and effects of gut hormones in three osteoblastic cell lines. BMC Physiol. 2011;11:12.","journal-title":"BMC Physiol"},{"issue":"4","key":"598_CR38","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1053\/gast.2001.22555","volume":"120","author":"PB Jeppesen","year":"2001","unstructured":"Jeppesen PB, Hartmann B, Thulesen J, Graff J, Lohmann J, Hansen BS, et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology. 2001;120(4):806\u201315.","journal-title":"Gastroenterology"},{"issue":"11","key":"598_CR39","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1080\/00365520802200028","volume":"43","author":"IB Gottschalck","year":"2008","unstructured":"Gottschalck IB, Jeppesen PB, Hartmann B, Holst JJ, Henriksen DB. Effects of treatment with glucagon-like peptide-2 on bone resorption in colectomized patients with distal ileostomy or jejunostomy and short-bowel syndrome. Scand J Gastroenterol. 2008;43(11):1304\u201310.","journal-title":"Scand J Gastroenterol"},{"issue":"8","key":"598_CR40","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1080\/00365520801965381","volume":"43","author":"IB Gottschalck","year":"2008","unstructured":"Gottschalck IB, Jeppesen PB, Holst JJ, Henriksen DB. Reduction in bone resorption by exogenous glucagon-like peptide-2 administration requires an intact gastrointestinal tract. Scand J Gastroenterol. 2008;43(8):929\u201337.","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"598_CR41","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.bone.2006.09.025","volume":"40","author":"DB Henriksen","year":"2007","unstructured":"Henriksen DB, Alexandersen P, Hartmann B, Adrian CL, Byrjalsen I, Bone HG, et al. Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women. Bone. 2007;40(3):723\u20139.","journal-title":"Bone"},{"issue":"1","key":"598_CR42","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bone.2003.09.009","volume":"34","author":"DB Henriksen","year":"2004","unstructured":"Henriksen DB, Alexandersen P, Byrjalsen I, Hartmann B, Bone HG, Christiansen C, et al. Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2. Bone. 2004;34(1):140\u20137.","journal-title":"Bone"},{"key":"598_CR43","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.bone.2015.08.006","volume":"81","author":"M Pereira","year":"2015","unstructured":"Pereira M, Jeyabalan J, J\u00f8rgensen CS, Hopkinson M, al-Jazzar A, Roux JP, et al. Chronic administration of glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice. Bone. 2015;81:459\u201367.","journal-title":"Bone"},{"issue":"12","key":"598_CR44","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1002\/jcp.25033","volume":"230","author":"SA Mansur","year":"2015","unstructured":"Mansur SA, Mieczkowska A, Bouvard B, Flatt PR, Chappard D, Irwin N, et al. Stable incretin mimetics counter rapid deterioration of bone quality in type 1 diabetes mellitus. J Cell Physiol. 2015;230(12):3009\u201318.","journal-title":"J Cell Physiol"},{"issue":"10","key":"598_CR45","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00198-019-04968-x","volume":"30","author":"K Hidayat","year":"2019","unstructured":"Hidayat K, Du X, Shi BM. Risk of fracture with dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in real-world use: systematic review and meta-analysis of observational studies. Osteoporos Int. 2019;30(10):1923\u201340.","journal-title":"Osteoporos Int"},{"issue":"12","key":"598_CR46","doi-asserted-by":"publisher","first-page":"e0187537","DOI":"10.1371\/journal.pone.0187537","volume":"12","author":"J Yang","year":"2017","unstructured":"Yang J, Huang C, Wu S, Xu Y, Cai T, Chai S, et al. The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: a network meta-analysis of randomized controlled trials. PLoS One. 2017;12(12):e0187537.","journal-title":"PLoS One"},{"issue":"5","key":"598_CR47","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s00223-015-0037-y","volume":"97","author":"JH Driessen","year":"2015","unstructured":"Driessen JH, et al. Use of glucagon-like-peptide 1 receptor agonists and risk of fracture as compared to use of other anti-hyperglycemic drugs. Calcif Tissue Int. 2015;97(5):506\u201315.","journal-title":"Calcif Tissue Int"},{"issue":"10","key":"598_CR48","doi-asserted-by":"publisher","first-page":"e10209","DOI":"10.1002\/jbm4.10209","volume":"3","author":"A Nissen","year":"2019","unstructured":"\u2022 Nissen A, et al. A pilot study showing acute inhibitory effect of GLP-1 on the bone resorption marker CTX in humans. JBMR Plus. 2019;3(10):e10209 Shows the BTM response to GIP and GLP-1 infusion.","journal-title":"JBMR Plus"},{"issue":"7","key":"598_CR49","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1210\/jc.2019-00008","volume":"104","author":"NC Bergmann","year":"2019","unstructured":"Bergmann NC, Lund A, Gasbjerg LS, J\u00f8rgensen NR, Jessen L, Hartmann B, et al. Separate and combined effects of GIP and GLP-1 infusions on bone metabolism in overweight men without diabetes. J Clin Endocrinol Metab. 2019;104(7):2953\u201360.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"598_CR50","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00198-004-1627-0","volume":"15","author":"O Johnell","year":"2004","unstructured":"Johnell O, Kanis JA. An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int. 2004;15(11):897\u2013902.","journal-title":"Osteoporos Int"},{"issue":"9","key":"598_CR51","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1007\/s00198-012-1964-3","volume":"23","author":"JA Kanis","year":"2012","unstructured":"Kanis JA, et al. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012;23(9):2239\u201356.","journal-title":"Osteoporos Int"},{"issue":"10","key":"598_CR52","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1210\/jc.2016-1915","volume":"101","author":"A Nordstrom","year":"2016","unstructured":"Nordstrom A, et al. Higher prevalence of type 2 diabetes in men than in women is associated with differences in visceral fat mass. J Clin Endocrinol Metab. 2016;101(10):3740\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"598_CR53","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.2337\/dc12-1188","volume":"36","author":"L Oei","year":"2013","unstructured":"Oei L, Zillikens MC, Dehghan A, Buitendijk GHS, Castano-Betancourt MC, Estrada K, et al. High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam study. Diabetes Care. 2013;36(6):1619\u201328.","journal-title":"Diabetes Care"},{"issue":"2","key":"598_CR54","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00223-016-0175-x","volume":"100","author":"J Starup-Linde","year":"2017","unstructured":"Starup-Linde J, Frost M, Vestergaard P, Abrahamsen B. Epidemiology of fractures in diabetes. Calcif Tissue Int. 2017;100(2):109\u201321.","journal-title":"Calcif Tissue Int"},{"key":"598_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.diabres.2016.03.009","volume":"115","author":"BN Conway","year":"2016","unstructured":"Conway BN, Long DM, Figaro MK, May ME. Glycemic control and fracture risk in elderly patients with diabetes. Diabetes Res Clin Pract. 2016;115:47\u201353.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"598_CR56","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/jbmr.3240","volume":"33","author":"EJ Samelson","year":"2018","unstructured":"Samelson EJ, Demissie S, Cupples LA, Zhang X, Xu H, Liu CT, et al. Diabetes and deficits in cortical bone density, microarchitecture, and bone size: Framingham HR-pQCT study. J Bone Miner Res. 2018;33(1):54\u201362.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"598_CR57","doi-asserted-by":"publisher","first-page":"e024067","DOI":"10.1136\/bmjopen-2018-024067","volume":"9","author":"H Wang","year":"2019","unstructured":"Wang H, Ba Y, Xing Q, du JL. Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis. BMJ Open. 2019;9(1):e024067.","journal-title":"BMJ Open"},{"issue":"3","key":"598_CR58","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1210\/clinem\/dgz153","volume":"105","author":"E Halper-Stromberg","year":"2020","unstructured":"Halper-Stromberg E, et al. Bone mineral density across the lifespan in patients with type 1 diabetes. J Clin Endocrinol Metab. 2020;105(3):746\u201353.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"598_CR59","doi-asserted-by":"publisher","first-page":"107324","DOI":"10.1016\/j.jdiacomp.2018.12.009","volume":"33","author":"ON Alhuzaim","year":"2019","unstructured":"Alhuzaim ON, Lewis EJH, Lovblom LE, Cardinez M, Scarr D, Boulet G, et al. Bone mineral density in patients with longstanding type 1 diabetes: results from the Canadian study of longevity in type 1 diabetes. J Diabetes Complicat. 2019;33(11):107324.","journal-title":"J Diabetes Complicat"},{"issue":"5","key":"598_CR60","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/jbmr.2118","volume":"29","author":"EJ Hothersall","year":"2014","unstructured":"Hothersall EJ, Livingstone SJ, Looker HC, Ahmed SF, Cleland S, Leese GP, et al. Contemporary risk of hip fracture in type 1 and type 2 diabetes: a national registry study from Scotland. J Bone Miner Res. 2014;29(5):1054\u201360.","journal-title":"J Bone Miner Res"},{"issue":"9","key":"598_CR61","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/dme.12734","volume":"32","author":"VN Shah","year":"2015","unstructured":"Shah VN, Shah CS, Snell-Bergeon JK. Type 1 diabetes and risk of fracture: meta-analysis and review of the literature. Diabet Med. 2015;32(9):1134\u201342.","journal-title":"Diabet Med"},{"issue":"4","key":"598_CR62","doi-asserted-by":"publisher","first-page":"E729","DOI":"10.1210\/jc.2013-3766","volume":"99","author":"SS Torekov","year":"2014","unstructured":"Torekov SS, Harsl\u00f8f T, Rejnmark L, Eiken P, Jensen JB, Herman AP, et al. A functional amino acid substitution in the glucose-dependent insulinotropic polypeptide receptor (GIPR) gene is associated with lower bone mineral density and increased fracture risk. J Clin Endocrinol Metab. 2014;99(4):E729\u201333.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-020-00598-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11914-020-00598-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-020-00598-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T15:05:24Z","timestamp":1650207924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11914-020-00598-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["598"],"URL":"https:\/\/doi.org\/10.1007\/s11914-020-00598-z","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"type":"print","value":"1544-1873"},{"type":"electronic","value":"1544-2241"}],"subject":[],"published":{"date-parts":[[2020,6,5]]},"assertion":[{"value":"5 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Viral Shah reports grants from T1D Exchange and Jaeb Center for Health Research, vTv Therapeutics, Sanofi US, Dexcom Inc., NovoNordisk, NIAMS (K23AR075099), NIDDK (1 R01 DK122554-01), Mylan GmBH, and the Juvenile Diabetes Research Foundation, outside the submitted work.Dr. Shah is on the advisory board for Sanofi US and Dexcom Inc.Vanessa Sherk reports grants from ASBMR (Rising Star Award) and NIH (KL2 TR002534), outside the submitted work.Irene Schauer declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}